Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19287166 | 1.00 | CA2 (0.44) | CA2TSHRALDH1A1NPSR1FAAH | |
| SCHEMBL19043424 | 1.00 | CA2 (0.44) | CA2TSHRALDH1A1NPSR1FAAH | |
| SCHEMBL7156770 | 0.86 | CA2 (0.45) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL7152435 | 0.86 | CA2 (0.45) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL649718 | 0.83 | CA2 (0.37) | CA2TSHRALDH1A1NPSR1 | |
| SCHEMBL815674 | 0.83 | CA2 (0.37) | CA2TSHRALDH1A1NPSR1 | |
| SCHEMBL10027882 | 0.83 | CA2 (0.37) | CA2TSHRALDH1A1NPSR1 | |
| SCHEMBL649719 | 0.83 | CA2 (0.37) | CA2TSHRALDH1A1NPSR1 | |
| SCHEMBL817984 | 0.81 | CA2 (0.38) | CA2TSHRALDH1A1NPSR1 | |
| SCHEMBL13130046 | 0.80 | CA2 (0.47) | CA2TSHRALDH1A1NPSR1TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119839-B2 | Carboxylic acid and antidepressant composition containing the same as active ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-8119839-B2 | Carboxylic acid and antidepressant composition containing the same as active ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20100184860-A1 | Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20100184860-A1 | Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient | YAMADA APICULTURE CENTER, INC. (JP) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184860-A1 | Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient | HSD17B11, HCAR2, HSD11B1 | CA2 251/4885TSHR 2525/4885ALDH1A1 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.